• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Obstet Gynecol Scand . Early suppression policies protected pregnant women from COVID-19 in 2020: A population-based surveillance from the Nor

tetano

Editor, Senior Moderator
Acta Obstet Gynecol Scand


. 2024 Feb 21.
doi: 10.1111/aogs.14808. Online ahead of print. Early suppression policies protected pregnant women from COVID-19 in 2020: A population-based surveillance from the Nordic countries

Reetta Varpula[SUP] 1 [/SUP], Outi Äyräs[SUP] 1 [/SUP], Anna J M Aabakke[SUP] 2 3 [/SUP], Kari Klungsøyr[SUP] 4 5 [/SUP], Teresia Svanvik[SUP] 6 [/SUP], Julia Kanerva[SUP] 6 [/SUP], Eva Jonasdottir[SUP] 7 [/SUP], Camilla Tjønneland Mentzoni[SUP] 5 [/SUP], Lars Thurn[SUP] 8 [/SUP], Elin Jones[SUP] 9 [/SUP], Lisa Fredriksson[SUP] 9 [/SUP], Karin Pettersson[SUP] 9 [/SUP], Lill Trine Nyfløt[SUP] 10 [/SUP], Siri Vangen[SUP] 10 [/SUP], Kjerstine Røe[SUP] 11 [/SUP], Pétur B Júlíusson[SUP] 12 [/SUP], Karin Källén[SUP] 13 [/SUP], Mika Gissler[SUP] 14 15 16 [/SUP], Aura Pyykönen[SUP] 17 [/SUP], Maija Jakobsson[SUP] 18 [/SUP], Lone Krebs[SUP] 3 19 [/SUP], Hilde Marie Engjom[SUP] 5 12 [/SUP]



Affiliations
Abstract

Introduction: The Coronavirus 2019 Disease (COVID-19) pandemic reached the Nordic countries in March 2020. Public health interventions to limit viral transmission varied across different countries both in timing and in magnitude. Interventions indicated by an Oxford Stringency Index ≥50 were implemented early (March 13-17, 2020) in Denmark, Finland, Norway and Iceland, and on March 26, 2020 in Sweden. The aim of the current study was to assess the incidence of COVID-19-related admissions of pregnant women in the Nordic countries in relation to the different national public health strategies during the first year of the pandemic.
Material and methods: This is a meta-analysis of population-based cohort studies in the five Nordic countries with national or regional surveillance in the Nordic Obstetric Surveillance System (NOSS) collaboration: national data from Denmark, Finland, Iceland and Norway, and regional data covering 31% of births in Sweden. The source population consisted of women giving birth in the included areas March 1-December 31, 2020. Pregnant women with a positive SARS-CoV-2 PCR test ≤14 days before hospital admission were included, and admissions were stratified as either COVID-19-related or non-COVID (other obstetric healthcare). Information about public health policies was retrieved retrospectively.
Results: In total, 392 382 maternities were considered. Of these, 600 women were diagnosed with SARS-CoV-2 infection and 137 (22.8%) were admitted for COVID-19 symptoms. The pooled incidence of COVID-19 admissions per 1000 maternities was 0.5 (95% confidence interval [CI] 0.2 to 1.2, I[SUP]2[/SUP] = 77.6, tau[SUP]2[/SUP] = 0.68, P = 0.0), ranging from no admissions in Iceland to 1.9 admissions in the Swedish regions. Interventions to restrict viral transmission were less stringent in Sweden than in the other Nordic countries.
Conclusions: There was a clear variation in pregnant women's risk of COVID-19 admission across countries with similar healthcare systems but different public health interventions to limit viral transmission. The meta-analysis indicates that early suppression policies protected pregnant women from severe COVID-19 disease prior to the availability of individual protection with vaccines.

Keywords: COVID-19; Nordic countries; SARS-CoV-2; incidence; pregnancy outcome; risk factor.

 
Back
Top Bottom